Primitive melanoma and covid-19: are we still paying the price of the pandemic?
J Eur Acad Dermatol Venereol
.
2022 Apr;36(4):e260-e261.
doi: 10.1111/jdv.17892.
Epub 2021 Dec 29.
Authors
F Ricci
1
,
G Di Lella
2
,
L Fania
3
,
F Ricci
4
,
L Sobrino
5
,
S Pallotta
3
,
A Panebianco
6
,
C Fortes
7
,
D Abeni
7
Affiliations
1
Melanoma Unit, IDI-IRCCS - FLMM, Rome, Italy.
2
Day Surgery Unit, IDI-IRCCS - FLMM, Rome, Italy.
3
Clinical Dermatology, IDI-IRCCS - FLMM, Rome, Italy.
4
Histopathology Unit, IDI-IRCCS - FLMM, Rome, Italy.
5
Informatic Systems, IDI-IRCCS - FLMM, Rome, Italy.
6
Medical direction, IDI-IRCCS - FLMM, Rome, Italy.
7
Clinical Epidemiology Unit, IDI-IRCCS - FLMM, Rome, Italy.
PMID:
34928528
DOI:
10.1111/jdv.17892
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Melanoma* / epidemiology
Pandemics
Skin Neoplasms* / epidemiology
Grants and funding
R.C. 4.3 2020/Ministero della Salute